NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Arbiom illustration
Durham-based Arbiom is challenging the world of animal feed by utilizing wood waste as a source of protein.
Mycovia logo
Durham’s Mycovia Pharmaceuticals is one of nine startups scrambling for last-minute votes in the “Buzz of BIO” Late Stage Leaders competition, part of the BIO Investor Forum taking place in San Francisco this October.
RFPi logo
RFPi, a Greenville medical device company, has landed a groundbreaking $1.49 million NIH grant with ECU as its academic research partner.
Transformation Talks logo
The North Carolina Biotechnology Center has launched the inaugural installment of its new podcast series, “Transformation Talks.” The 22-minute program, hosted by Jim Shamp, NCBiotech’s director of public relations, features former Biotech Center president Charles Hamner Jr., D.V.M., and Bill Bullock, senior vice president of economic development and statewide operations.
AES logo
Accelerated Enrollment Solutions, a business unit of Wilmington’s Pharmaceutical Product Development, has purchased the clinical research site business of clinical trial development company Bioclinica.
KBI Biopharma logo
Durham contract services organization KBI Biopharma is working with two other companies to develop a novel therapy to treat inflammatory diseases.
Sara Imhof BIO panel
North Carolina is taking an increasing leadership role in precision health as we apply new technologies to our deepening understanding of how people’s genetic makeup and other factors impact their wellbeing.
iStock helix illustration
Registration is open for the Sept. 25 and 26 "Invest in Cures & Rare Disease Forum," bringing together potential investors, collaborators and NC therapeutics developers to find new ways to deal with orphan diseases.
Viralgen logo , AskBio logo
Viralgen, a Spanish contract development and manufacturing organization half owned by AskBio of Research Triangle Park, has gained vital regulatory status in Europe for producing gene therapies using AskBio’s manufacturing process.
Shutterstock photo of eye exam
Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, has begun patient dosing in a first-in-human clinical trial of an implantable drug for treating two retinal diseases.
Ag Innovation Showcase
The 11th annual Ag Innovation Showcase will connect the relationship of health in food production and the environment. The Guthrie in Minneapolis will be hosting the Showcase September 9-11, offering expert panels with rapid-fire discussions, spotlight sessions, and representation from multiple agribusiness companies.
Thermo Fisher Employee demonstrating VR technology
Thermo Fisher Scientific has a new virtual reality training facility that will mimic real-world operating environments as a way to train new employees on the sterile injectibles drug production lines.
JLL life science report 2019
North Carolina’s Raleigh-Durham metro area, a.k.a. the Research Triangle, has the nation’s fourth-leading life science base among major metro hubs, according to a new report.
Pyxus logo
Pyxus International, a Morrisville-based global agricultural company, has signed an agreement with Cornell University to fill a gap in hemp cultivation knowledge.
GeneCentric logo
Research Triangle Park-based GeneCentric Therapeutics has acquired a sister precision medicine cancer start-up, Chapel Hill’s Select ImmunoGenomics.